Abstract
Rationale
Dysregulation of the endocannabinoid (eCB) system by high doses of Δ9-tetrahydrocannabinol (THC) is hypothesized to generate a dysfunctional hypothalamic-pituitary-adrenal (HPA) axis contributing to cannabinoid hyperemesis syndrome (CHS).
Objectives and methods
Using the conditioned gaping model of nausea, we aimed to determine if pre-treatments that interfere with stress, or an anti-emetic drug, interfere with THC-induced nausea in male rats. The corticotropin-releasing hormone (CRH) antagonist, antalarmin, was given to inhibit the HPA axis during conditioning. Since eCBs inhibit stress, MJN110 (which elevates 2-arachidonylglycerol (2-AG)) and URB597 (which elevates anandamide (AEA)) were also tested. Propranolol (β-adrenergic antagonist) and WAY-100635 (5-HT1A antagonist) attenuate HPA activation by cannabinoids and, therefore, were assessed. In humans, CHS symptoms are not alleviated by anti-emetic drugs, such as ondansetron (5-HT3 antagonist); however, benzodiazepines are effective. Therefore, ondansetron and chlordiazepoxide were tested. To determine if HPA activation by THC is dose-dependent, corticosterone (CORT) was analyzed from serum of rats treated with 0.0, 0.5, or 10 mg/kg THC.
Results
Antalarmin (10 and 20 mg/kg), MJN110 (10 mg/kg), URB597 (0.3 mg/kg), propranolol (2.5 and 5 mg/kg), WAY-100635 (0.5 mg/kg), and chlordiazepoxide (5 mg/kg) interfered with THC-induced conditioned gaping, but the anti-emetic ondansetron (0.1 and 0.01 mg/kg) did not. THC produced significantly higher CORT levels at 10 mg/kg than at 0.0 and 0.5 mg/kg THC.
Conclusions
Treatments that interfere with the stress response also inhibit THC-induced conditioned gaping, but a typical anti-emetic drug does not, supporting the hypothesis that THC-induced nausea, and CHS, is a result of a dysregulated stress response.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abalo R, Cabezos PA, López-Miranda V et al (2009) Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat. Neurogastroenterol Motil 21:22–24. https://doi.org/10.1111/j.1365-2982.2009.01315.x
Abalo R, Cabezos PA, Vera G, López-miranda V, Herradón E, Martín-fontelles MI (2011) Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors. Neurogastroenterol Motil 23:457–468. https://doi.org/10.1111/j.1365-2982.2011.01677.x
Allen JH, De Moore G, Heddle R, Twartz J (2004) Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 53:1566–1570. https://doi.org/10.1136/gut.2003.036350
Alshaarawy O, Elbaz HA (2016) Cannabis use and blood pressure levels: United States national health and nutrition examination survey, 2005-2012. J Hypertens 34:1507–1512. https://doi.org/10.1016/j.physbeh.2017.03.040
Andrykowski MA (1990) The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis. Psychosom Med 52:458–475. https://doi.org/10.1097/00006842-199007000-00008
Aviello G, Romano B, Izzo A (2008) Cannabinoids and gastrointestinal motility: animal and human studies. Eur Rev Med Pharmacol Sci 12:81–93
Bambico FR, Katz N, Debonnel G, Gobbi G (2007) Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 27:11700–11711. https://doi.org/10.1523/JNEUROSCI.1636-07.2007
Bernstein IL, Chavez M, Allen D, Taylor EM (1992) Area postrema mediation of physiological and behavioral effects of lithium chloride in the rat. Brain Res 575:132–137. https://doi.org/10.1016/0006-8993(92)90432-9
Blumentrath CG, Dohrmann B, Ewald N (2017) Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment. Ger Med Sci 15:Doc06. https://doi.org/10.3205/000247
Camilleri M, Parkman HP, Shafi M, Abell TL, Gerson L, American College of Gastroenterology (2013) Clinical guideline: management of gastroparesis. Am J Gastroenterol 108:18–38. https://doi.org/10.1038/ajg.2012.373.Clinical
Chang YH, Windish DM (2009) Cannabinoid hyperemesis relieved by compulsive bathing CASE REPORT. Mayo Clin Proc 84:76–78. https://doi.org/10.4065/84.1.76
Cluny NL, Naylor RJ, Whittle BA, Javid FA (2008) The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus. Basic Clin Pharmacol Toxicol 103:150–156. https://doi.org/10.1111/j.1742-7843.2008.00253.x
Corchero J, Romero J, Berrendero F, Fernandez-Ruiz J, Ramos JA, Fuentes JA, Manzanares J (1999) Time-dependent differences of repeated administration with Δ9- tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by μ-opioid and CB1-cannabinoid receptors in the caudate-putamen. Mol Brain Res 67:148–157. https://doi.org/10.1016/S0169-328X(99)00053-4
Critchley DJP, Childs KJ, Middlefell VC, Dourish CT (1994) Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635. Eur J Pharmacol 264:95–97. https://doi.org/10.1016/0014-2999(94)90642-4
Cuttler C, Spradlin A, Nusbaum AT, Whitney P, Hinson JM, McLaughlin RJ (2017) Blunted stress reactivity in chronic cannabis users. Psychopharmacology 234:2299–2309. https://doi.org/10.1007/s00213-017-4648-z
Darmani NA (2001) Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew. Pharmacol Biochem Behav 69:239–249. https://doi.org/10.1016/S0091-3057(01)00531-7
De Fonseca FR, Gorriti MA, Fernández-Ruiz JJ et al (1994) Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav 47:33–40. https://doi.org/10.1016/0091-3057(94)90108-2
Deak T, Nguyen KT, Ehrlich AL et al (1999) The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140:79–86
DeVuono MV, Parker LA (2020) Cannabinoid hyperemesis syndrome : a review of potential mechanisms. Cannabis Cannabinoid Res:1–13. https://doi.org/10.1089/can.2019.0059
DeVuono MV, Hrelja KM, Sabaziotis L, Rajna A, Rock EM, Limebeer CL, Mutch DM, Parker LA (2018) Conditioned gaping produced by high dose Δ9-tetrahydracannabinol: dysregulation of the hypothalamic endocannabinoid system. Neuropharmacology 141:272–282. https://doi.org/10.1016/j.neuropharm.2018.08.039
DeVuono MV, Hrelja KM, Petrie GN, Limebeer CL, Rock EM, Hill MN, Parker LA (2020) Nausea-induced conditioned gaping reactions in rats produced by high-dose synthetic cannabinoid, JWH-018. Cannabis Cannabinoid Res. https://doi.org/10.1089/can.2019.0103
Di Marzo V, Berrendero F, Bisogno T et al (2000) Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of Δ9-tetrahydrocannabinol-tolerant rats. J Neurochem 74:1627–1635. https://doi.org/10.1046/j.1471-4159.2000.0741627.x
Di S, Malcher-Lopes R, Halmos KC, Tasker JG (2003) Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23:4850–4857
Eckel LA, Ossenkopp K-P (1996) Area postrema mediates the formation of rapid, conditioned palatability shifts in lithium-treated rats. Behav Neurosci 110:202–212. https://doi.org/10.1037/0735-7044.110.1.202
Endo T, Takahashi M, Minami M (1995) Changes in the afferent abdominal vagal nerve activity induced by cisplatin and copper sulfate in the ferret. Biog Amin 11:399–407
Evanson NK, Tasker JG, Hill MN, Hillard CJ, Herman JP (2010) Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 151:4811–4819. https://doi.org/10.1210/en.2010-0285
Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3’-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313(1):352–358
Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJP, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT (1995) Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 73:337–353. https://doi.org/10.1016/0166-4328(96)00118-0
Frytak S, Moertel C, O’Fallon JR et al (1979) Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. Ann Intern Med 19:825–830
Galli JA, Sawaya R, Friedenberg F (2013) Cannabinoid hyperemesis syndrome. CNS Neurosci Ther 19:994–995. https://doi.org/10.1111/cns.12207
Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102:18620–18625. https://doi.org/10.1073/pnas.0509591102
González S, Fernández-Ruiz J, Di Marzo V et al (2004) Behavioral and molecular changes elicited by acute administration of SR141716 to Δ9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. Drug Alcohol Depend 74:159–170. https://doi.org/10.1016/j.drugalcdep.2003.12.011
Gorzalka BB, Hill MN, Hillard CJ (2008) Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci Biobehav Rev 32:1152–1160. https://doi.org/10.1016/j.neubiorev.2008.03.004
Gray JM, Vecchiarelli HA, Morena M, Lee TTY, Hermanson DJ, Kim AB, McLaughlin RJ, Hassan KI, Kuhne C, Wotjak CT, Deussing JM, Patel S, Hill MN (2015) Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. J Neurosci 35:3879–3892. https://doi.org/10.1523/jneurosci.2737-14.2015
Grill H, Norgren R (1978) Chronically decerebrate rats demonstrate satiation but not bait shyness. Science (80- ) 201:267–269. https://doi.org/10.1126/science.663655
Gunduz-Cinar O, MacPherson KP, Cinar R et al (2013) Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry 18:813–823. https://doi.org/10.1038/mp.2012.72
Hill MN, Tasker JG (2012) Endocannabinoid signaling, glucocorticoid-mediated negative feedback and regulation of the HPA axis. Neuroscience 204:5–16. https://doi.org/10.1016/j.neuroscience.2011.12.030.Endocannabinoid
Hirvonen J, Goodwin RS, Li C-T, Terry GE, Zoghbi SS, Morse C, Pike VW, Volkow ND, Huestis MA, Innis RB (2012) Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 17:642–649. https://doi.org/10.1038/mp.2011.82
Hockman CH, Perrin RG, Kalant H (1971) Electroencephalographic and behavioral alterations produced by delta-9-tetrahydrocannabinol. Science (80- ) 172:968–970
Horn CC, Richardson EJ, Andrews PLR, Friedman MI (2004) Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti-cancer agent cisplatin. Auton Neurosci Basic Clin 115:74–81. https://doi.org/10.1016/j.autneu.2004.08.011
Izzo AA, Mascolo N, Capasso R, Germanò MP, de Pasquale R, Capasso F (1999) Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Naunyn Schmiedeberg’s Arch Pharmacol 360:221–223. https://doi.org/10.1007/s002109900054
Jones RT (2002) Cardiovascular system effects of marijuana. J Clin Pharmacol 42:58S–63s. https://doi.org/10.1002/j.1552-4604.2002.tb06004.x
Kalsbeek A, van der Spek R, Lei J, Endert E, Buijs RM, Fliers E (2012) Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis. Mol Cell Endocrinol 349:20–29. https://doi.org/10.1016/j.mce.2011.06.042
Kamen C, Tejani MA, Chandwani K, Janelsins M, Peoples AR, Roscoe JA, Morrow GR (2014) Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol 722:172–179. https://doi.org/10.1016/j.ejphar.2013.09.071
Khattar N, Routsolias JC (2017) Emergency department treatment of cannabinoid hyperemesis syndrome : a review. Am J Ther 5:1–5. https://doi.org/10.1097/MJT.0000000000000655
King GR, Ernst T, Deng W, Stenger A, Gonzales RMK, Nakama H, Chang L (2011) Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels. J Neurosci 31:17923–17931. https://doi.org/10.1523/JNEUROSCI.4148-11.2011
Krowicki ZK, Moerschbaecher JM, Winsauer PJ, Digavalli SV, Hornby PJ (1999) Δ9-Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors. Eur J Pharmacol 371:187–196. https://doi.org/10.1016/S0014-2999(99)00165-X
Le Fur G, Guilloux F, Mitrani N et al (1979) Relationships between plasma corticosteroids and benzodiazepines in stress. J Pharmacol Exp Ther 211:305–308
Levinthal DJ, Bielefeldt K (2014) Adult cyclical vomiting syndrome: a disorder of allostatic regulation? Exp Brain Res 232:2541–2547. https://doi.org/10.1007/s00221-014-3939-4
Limebeer CL, Parker LA (1999) Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea. Neuroreport 10:3769–3772
Limebeer CL, Parker LA (2000) The antiemetic drug ondansetron interferes with lithium-induced conditioned rejection reactions, but not lithium-induced taste avoidance in rats. J Exp Psychol Anim Behav Process 26:371–384. https://doi.org/10.1037/0097-7403.26.4.371
Limebeer CL, Hall G, Parker LA (2006) Exposure to a lithium-paired context elicits gaping in rats: a model of anticipatory nausea. Physiol Behav 88:398–403. https://doi.org/10.1016/j.physbeh.2006.04.014
Limebeer CL, Rock EM, Mechoulam R, Parker LA (2012) The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex. Br J Pharmacol 167:1126–1136. https://doi.org/10.1111/j.1476-5381.2012.02066.x
Limebeer CL, Rock EM, Parker LA (2017) Nausea-induced 5-HT release in the interoceptive insular cortex is reversed by systemic MAGL inhibition. In: Internation Cannabinoid Research Society. p 48
Limebeer CL, Rock EM, Sharkey KA, Parker LA (2018) Nausea-induced 5-HT release in the interoceptive insular cortex and regulation by monoacylglycerol lipase (MAGL) inhibition and cannabidiol. eNeuro 5:1–10. doi: https://doi.org/10.1523/ENEURO.0256-18.2018 LK - http://RJ2HH4RA6G.search.serialssolutions.com?sid=EMBASE&issn=23732822&id=doi:10.1523%2FENEURO.0256-18.2018&atitle=Nausea-induced+5-HT+release+in+the+interoceptive+insular+cortex+and+regulation+by+monoacylglycerol+lipase+%28MAGL%29+inhibition+and+cannabidiol&stitle=eNeuro&title=eNeuro&volume=5&issue=4&spage=&epage=&aulast=Limebeer&aufirst=Cheryl+L.&auinit=C.L.&aufull=Limebeer+C.L.&coden=&isbn=&pages=-&date=2018&auinit1=C&auinitm=L
Lu MLRY, Agito MD (2015) Cannabinoid hyperemesis syndrome: marijuana is both antiemetic and proemetic. Cleve Clin J Med 82:429–434. https://doi.org/10.3949/ccjm.82a.14023
Malik Z, Baik D, Schey R (2015). The role of cannabinoids in regulation of nausea and vomiting, and visceral pain. doi: https://doi.org/10.1007/s11894-015-0429-1.
McCall JG, Al-Hasani R, Siuda ER et al (2015) CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety. Neuron 87:605–620. https://doi.org/10.1016/j.neuron.2015.07.002
McCallum RW, Soykan I, Sridhar KR et al (1999) Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther 13:77–80. https://doi.org/10.1046/j.1365-2036.1999.00441.x
McLaughlin RJ, Hill MN, Gorzalka BB (2009) Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis. Eur J Pharmacol 624:71–76. https://doi.org/10.1016/j.ejphar.2009.09.055
Mechoulam R, Gaoni Y (1965) A total synthesis of dl-delta-1-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87:3273–3275
Mikkelsen JD, Søderman A, Kiss A, Mirza N (2005) Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis. Eur J Pharmacol 519:223–230. https://doi.org/10.1016/j.ejphar.2005.06.049
Mooventhan A, Nivethitha L (2014) Scientific evidence-based effects of hydrotherapy on various systems of the body article. N Am J Med Sci 6:199–209. https://doi.org/10.4103/1947
Morgan CJA, Page E, Schaefer C, Chatten K, Manocha A, Gulati S, Curran HV, Brandner B, Leweke FM (2013) Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. Br J Psychiatry 202:381–382. https://doi.org/10.1192/bjp.bp.112.121178
Muniyappa R, Sable S, Ouwerkerk R, Mari A, Gharib AM, Walter M, Courville A, Hall G, Chen KY, Volkow ND, Kunos G, Huestis MA, Skarulis MC (2013) Metabolic effects of chronic cannabis smoking. Diabetes Care 36:2415–2422. https://doi.org/10.2337/dc12-2303
Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M (2006) Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur J Neurosci 23:2385–2394. https://doi.org/10.1111/j.1460-9568.2006.04759.x
Murphy LL, Muñoz RM, Adrian BA, Villanúa MA (1998) Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol Dis 5:432–446. https://doi.org/10.1006/nbdi.1998.0224
Nagasawa Y, Komori S, Sato M et al (2001) Effects of hot bath immersion on autonomic activity and hemodynamics. Jpn Circ J 65:587–592. https://doi.org/10.1016/0195-6701(91)90034-6
Nakade Y, Tsuchida D, Fukuda H, et al. (2005). Restraint stress delays solid gastric emptying via a central CRF and peripheral sympathetic neuron in rats. 27705:427–432. doi: https://doi.org/10.1152/ajpregu.00499.2004
Napadow V, Sheehan JD, Kim J, LaCount LT, Park K, Kaptchuk TJ, Rosen BR, Kuo B (2013) The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex 23:806–813. https://doi.org/10.1093/cercor/bhs073
Niphakis MJ, Cognetta AB, Chang JW, Buczynski MW, Parsons LH, Byrne F, et al (2013) Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. ACS Chem Neurosci 4(9):1322–1332
Noyes R, Brunk SF, Baram DA, Canter A (1975) The analgesic properties of delta-9-tetrahydrocannabinol and codeine. J Clin Pharmacol 15:84–89
Otto B, Riepl RL, Klosterhalfen S, Enck P (2006) Endocrine correlates of acute nausea and vomiting. Auton Neurosci Basic Clin 129:17–21. https://doi.org/10.1016/j.autneu.2006.07.010
Papini S, Ruglass LM, Lopez-Castro T, Powers MB, Smits JAJ, Hien DA (2017) Chronic cannabis use is associated with impaired fear extinction in humans. J Abnorm Psychol 126:117–124. https://doi.org/10.1037/abn0000224
Parker LA (2014) Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea. Eur J Pharmacol 722:122–133. https://doi.org/10.1016/j.ejphar.2013.09.070
Parker LA, Gillies T (1995) THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behav Neurosci 109:71–78
Parker LA, Kwiatkowska M, Mechoulam R (2006) Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: an animal model of anticipatory nausea and vomiting. Physiol Behav 87:66–71. https://doi.org/10.1016/j.physbeh.2005.08.045
Parker LA, Niphakis MJ, Downey R, Limebeer CL, Rock EM, Sticht MA, Morris H, Abdullah RA, Lichtman AH, Cravatt BF (2015) Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus. Psychopharmacology 232:583–593. https://doi.org/10.1007/s00213-014-3696-x
Patel S, Hillard CJ (2009) Role of endocannabinoid signaling in anxiety and depression. Curr Top Behav Neurosci 1(1):87–110. https://doi.org/10.1007/978-3-540-88955-7
Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ (2004) Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145:5431–5438. https://doi.org/10.1210/en.2004-0638
Pertwee RG (2009) Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 156:397–411. https://doi.org/10.1111/j.1476-5381.2008.00048.x
Puder M, Weidenfeld J, Chowers I, Nir I, Conforti N, Siegel RA (1982) Corticotrophin and corticosterone secretion following Δ1-tetrahydrocannabinol, in intact and in hypothalamic deafferentated male rats. Exp Brain Res 46:85–88. https://doi.org/10.1007/BF00238101
Razavi D, Delvaux N, Faravacques C et al (1993) Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 11:1384–1390
Richards JR (2017) Cannabinoid hyperemesis syndrome: a disorder of the HPA axis and sympathetic nervous system? Med Hypotheses 103:90–95. https://doi.org/10.1016/j.mehy.2017.04.018
Richards JR, Dutczak O (2017) Propranolol treatment of cannabinoid hyperemesis syndrome. J Clin Psychopharmacol 37:482–484. https://doi.org/10.1097/JCP.0000000000000735
Richards JR, Gordon BK, Danielson AR, Moulin AK (2017) Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review. Pharmacother J Hum Pharmacol Drug Ther 37:725–734. https://doi.org/10.1002/phar.1931
Rock EM, Bolognini D, Limebeer CL, Cascio MG, Anavi-Goffer S, Fletcher PJ, Mechoulam R, Pertwee RG, Parker LA (2012) Cannabidiol, a nonpsychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT 1A somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol 165:2620–2634. https://doi.org/10.1111/j.1476-5381.2011.01621.x
Rock EM, Limebeer CL, Navaratnam R, Sticht MA, Bonner N, Engeland K, Downey R, Morris H, Jackson M, Parker LA (2014) A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping. Psychopharmacology 231:3207–3215. https://doi.org/10.1007/s00213-014-3498-1
Rock EM, Moreno-Sanz G, Limebeer CL, Petrie GN, Angelini R, Piomelli D, Parker LA (2017) Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPARα and CB1 receptors. Br J Pharmacol 174:3837–3847. https://doi.org/10.1111/bph.13980
Scheckel CL, Boff E, Dahlen P, Smart T (1968) Behavioral effects in monkeys of racemates of two biologically active marijuana constituents. Science (80- ) 160:1467–1469
Sclocco R, Kim J, Garcia RG, Sheehan JD, Beissner F, Bianchi AM, Cerutti S, Kuo B, Barbieri R, Napadow V (2016) Brain circuitry supporting multi-organ autonomic outflow in response to nausea. Cereb Cortex 26:485–497. https://doi.org/10.1093/cercor/bhu172
Shader RI, Greenblatt DJ (1993) Use of benzodiazepines in anxiety disorders. N Engl J Med 328:1398–1405
Shannon HE, Martin WR, Silcox D (1978) Lack of antiemetic effects of delta-9-tetrahydracannabinoil in apomorphine-induced emesis in the dog. Life Sci 23:49–53
Sidney S (2002) Cardiovascular consequences of marijuana use. J Clin Pharmacol 42:64–70. https://doi.org/10.1177/0091270002238796
Sim-selley LJ (2003) Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol 15:1–12
Somaini L, Manfredini M, Amore M, Zaimovic A, Raggi MA, Leonardi C, Gerra ML, Donnini C, Gerra G (2012) Psychobiological responses to unpleasant emotions in cannabis users. Eur Arch Psychiatry Clin Neurosci 262:47–57. https://doi.org/10.1007/s00406-011-0223-5
Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA (2017) Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment—a systematic review. J Med Toxicol 13:71–87. https://doi.org/10.1007/s13181-016-0595-z
Stanghellini V, Tack J (2014) Gastroparesis: separate entity or just a part of dyspepsia? Gut 63:1972–1978. https://doi.org/10.1136/gutjnl-2013-306084
Stanghellini V, Chan FKL, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ (2016) Gastroduodenal disorders. Gastroenterology 150:1380–1392. https://doi.org/10.1053/j.gastro.2016.02.011
Sticht MA, Limebeer CL, Rafla BR, Parker LA (2015) Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats. Neuroscience 286:338–344. https://doi.org/10.1016/j.neuroscience.2014.11.058
Sticht MA, Limebeer CL, Rafla BR, Abdullah RA, Poklis JL, Ho W, Niphakis MJ, Cravatt BF, Sharkey KA, Lichtman AH, Parker LA (2016) Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex. Neuropharmachology 102:92–102. https://doi.org/10.1245/s10434-014-3918-9.Randomized
Taché Y (1999) Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis. Dig Dis Sci 44:79S–86S
Taché Y, Bonaz B (2009) Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 117:33–40. https://doi.org/10.1172/JCI30085.in
Taché Y, Perdue MH (2004) Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 16:137–142. https://doi.org/10.1111/j.1743-3150.2004.00490.x
Tai S, Hyatt WS, Gu C, Franks LN, Vasiljevik T, Brents LK, Prather PL, Fantegrossi WE (2015) Repeated administration of phytocannabinoid Δ9-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner. Pharmacol Res 102:22–32. https://doi.org/10.1016/j.phrs.2015.09.006
Tuerke KJ, Limebeer CL, Fletcher PJ, Parker LA (2012) Double dissociation between regulation of conditioned disgust and taste avoidance by serotonin availability at the 5-HT3 receptor in the posterior and anterior insular cortex. J Neurosci 32:13709–13717. https://doi.org/10.1523/JNEUROSCI.2042-12.2012
Van Sickle MD, Oland LD, Mackie K et al (2003) Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am J Physiol Gastrointest Liver Physiol 285:G566–G576. https://doi.org/10.1152/ajpgi.00113.2003
Vandrey R, Umbricht A, Strain EC (2011) Increased blood pressure after abrupt cessation of daily cannabis use. J Addict Med 5:16–20. https://doi.org/10.1097/ADM.0b013e3181d2b309
Vaziri ND, Thomas R, Stearling M et al (1981) Toxicity with intravenous injection of crude marijuana extract. Clin Toxicol 18:353–366
Venkatesan T, Zadvornova Y, Raff H, Hillard CJ (2016) Endocannabinoid-related lipids are increased during an episode of cyclic vomiting syndrome. Neurogastroenterol Motil 28:1409–1418. https://doi.org/10.1111/nmo.12843
Venkatesan T, Levinthal DJ, Li BUK, Tarbell SE, Adams KA, Issenman RM, Sarosiek I, Jaradeh SS, Sharaf RN, Sultan S, Stave CD, Monte AA, Hasler WL (2019) Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Neurogastroenterol Motil 31:1–14. https://doi.org/10.1111/nmo.13606
Verge D, Daval G, Patey A, Gozlan H, el Mestikawy S, Hamon M (1985) Presynaptic 5-HT autoreceptors on serotonergic cell bodies and /or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharacology 113:463–464
Webster EL, Lewis DB, Torpy DJ et al (1996) In vivo and in vitro characterization releasing hormone (CRH) receptor release and peripheral inflammation of antalarmin, a nonpeptide corticotropin-antagonist: suppression of pituitary ACTH. Endocrinology 137:3–6
Zorrilla EP, Valdez GR, Nozulak J, et al (2002). Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. 952:188–199
Funding
This research was supported by research grants from the Natural Sciences and Engineering Research Council of Canada (NSERC-03629) and the Canadian Institutes of Health Research (CIHR-388239) to LAP.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
DeVuono, M.V., La Caprara, O., Sullivan, M.T. et al. Role of the stress response and the endocannabinoid system in Δ9-tetrahydrocannabinol (THC)-induced nausea. Psychopharmacology 237, 2187–2199 (2020). https://doi.org/10.1007/s00213-020-05529-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-020-05529-5